-
-
在线客服
-
-
-
-
我的收藏
-
我的订单
-
快速订购
-
-
-
| 产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
|---|---|---|---|---|
| A998399 | Anti-Amyloid Beta Reference Antibody (donanemab), Anti-Amyloid Beta Reference Antibody (donanemab), |
|||
| A998400 | Anti-Amyloid Beta Reference Antibody (gantenerumab), Anti-Amyloid Beta Reference Antibody (gantenerumab), |
|||
| A998401 | Anti-Amyloid Beta Reference Antibody (Georgetown U. patent anti-Amyloid Beta), Anti-Amyloid Beta Reference Antibody (Georgetown U. patent anti-Amyloid Beta), |
|||
| A998402 | Anti-Amyloid Beta Reference Antibody (GSK 933776), Anti-Amyloid Beta Reference Antibody (GSK 933776), |
|||
| A998403 | Anti-Amyloid Beta Reference Antibody (Kumamoto U. patent anti-Amyloid Beta), Anti-Amyloid Beta Reference Antibody (Kumamoto U. patent anti-Amyloid Beta), |
|||
| A998404 | Anti-Amyloid Beta Reference Antibody (lecanemab), Anti-Amyloid Beta Reference Antibody (lecanemab), |
|||
| A998405 | Anti-Amyloid Beta Reference Antibody (Merck anti-Amyloid beta 19.3), Anti-Amyloid Beta Reference Antibody (Merck anti-Amyloid beta 19.3), |
|||
| A998406 | Anti-Amyloid Beta Reference Antibody (Merck patent anti-Amyloid Beta), Anti-Amyloid Beta Reference Antibody (Merck patent anti-Amyloid Beta), |
|||
| A998407 | Anti-Amyloid Beta Reference Antibody (ponezumab), Anti-Amyloid Beta Reference Antibody (ponezumab), |
|||
| A998408 | Anti-Amyloid Beta Reference Antibody (Rockefeller U. patent anti-Amyloid Beta), Anti-Amyloid Beta Reference Antibody (Rockefeller U. patent anti-Amyloid Beta), |
|||
| A998409 | Anti-Amyloid Beta Reference Antibody (solanezumab), Anti-Amyloid Beta Reference Antibody (solanezumab), |
|||
| A998410 | Anti-Amyloid Beta Reference Antibody (U.Illinois scFv59), Anti-Amyloid Beta Reference Antibody (U.Illinois scFv59), |
|||
| A998411 | Anti-Amyloid Beta Reference Antibody (U.Zurich patent anti-Amyloid Beta), Anti-Amyloid Beta Reference Antibody (U.Zurich patent anti-Amyloid Beta), |
|||
| A998412 | Anti-ANGPT2 Reference Antibody (MEDI3617), Anti-ANGPT2 Reference Antibody (MEDI3617), |
|||
| A998413 | Anti-ANGPT2 Reference Antibody (nesvacumab), Anti-ANGPT2 Reference Antibody (nesvacumab), |
|||
| A998414 | Anti-ANGPT2 Reference Antibody (Roche patent anti-ANG-2), Anti-ANGPT2 Reference Antibody (Roche patent anti-ANG-2), |
|||
| A998415 | Anti-ANGPT2 Reference Antibody (zansecimab), Anti-ANGPT2 Reference Antibody (zansecimab), |
|||
| A998416 | Anti-ANGPTL3 Reference Antibody (evinacumab), Anti-ANGPTL3 Reference Antibody (evinacumab), |
|||
| A998417 | Anti-ANGPTL4 Reference Antibody (Nanyang Tech.U. patent anti-ANGPTL4), Anti-ANGPTL4 Reference Antibody (Nanyang Tech.U. patent anti-ANGPTL4), |
|||
| A998418 | Anti-ANGPTL8 Reference Antibody (Regeneron patent anti-ANGPTL8), Anti-ANGPTL8 Reference Antibody (Regeneron patent anti-ANGPTL8), |
